You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$7.65K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Jun 30, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$541.83
Jun 30, 2026
First close after public filing
$555.91
Jul 2, 2026
30-day return after filing
-6.87%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 14 shares @ $546.6
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000089
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$6.43M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Jun 30, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $58.99K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $278.55K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $532.04K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $706.77K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $1.35M |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $586.57K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $239.05K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $36.03K |
| United Therapeutics Corp UTHR Current | Sale | Jun 30, 2026 | $7.65K |
| United Therapeutics Corp UTHR | Sale | Jun 30, 2026 | $131.82K |
| United Therapeutics Corp UTHR | Exercise | Jun 30, 2026 | $0 |